These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22348968)

  • 21. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
    Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
    Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs and their regulatory roles in animals and plants.
    Zhang B; Wang Q; Pan X
    J Cell Physiol; 2007 Feb; 210(2):279-89. PubMed ID: 17096367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of microRNAs in stem/progenitor cells and cardiovascular repair.
    Jakob P; Landmesser U
    Cardiovasc Res; 2012 Mar; 93(4):614-22. PubMed ID: 22135162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of microRNAs to Cancer Therapy].
    Iguchi H; Ochiya T
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):389-95. PubMed ID: 20332672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
    Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
    Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overgrowth caused by misexpression of a microRNA with dispensable wild-type function.
    Nairz K; Rottig C; Rintelen F; Zdobnov E; Moser M; Hafen E
    Dev Biol; 2006 Mar; 291(2):314-24. PubMed ID: 16443211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human microRNA clusters: genomic organization and expression profile in leukemia cell lines.
    Yu J; Wang F; Yang GH; Wang FL; Ma YN; Du ZW; Zhang JW
    Biochem Biophys Res Commun; 2006 Oct; 349(1):59-68. PubMed ID: 16934749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transcriptional regulation of microRNA expression.
    Obernosterer G; Leuschner PJ; Alenius M; Martinez J
    RNA; 2006 Jul; 12(7):1161-7. PubMed ID: 16738409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
    Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
    Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs in normal and cancer cells: a new class of gene expression regulators.
    Bagnyukova TV; Pogribny IP; Chekhun VF
    Exp Oncol; 2006 Dec; 28(4):263-9. PubMed ID: 17285108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs: novel mediators of resistance to microtubule-targeting agents.
    Kanakkanthara A; Miller JH
    Cancer Treat Rev; 2013 Apr; 39(2):161-70. PubMed ID: 22902296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-mediated posttranscriptional mechanisms of gene expression in proliferating and quiescent cancer cells.
    Letonqueze O; Lee J; Vasudevan S
    RNA Biol; 2012 Jun; 9(6):871-80. PubMed ID: 22699554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs and human cancer.
    Nikitina EG; Urazova LN; Stegny VN
    Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the miR-148/-152 family in physiology and disease.
    Friedrich M; Pracht K; Mashreghi MF; Jäck HM; Radbruch A; Seliger B
    Eur J Immunol; 2017 Dec; 47(12):2026-2038. PubMed ID: 28880997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment.
    Gao Y; Feng B; Han S; Lu L; Chen Y; Chu X; Wang R; Chen L
    Cell Physiol Biochem; 2016; 39(6):2186-2202. PubMed ID: 27802440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-17-92 cluster is a novel regulatory gene of cardiac ischemic/reperfusion injury.
    Zhou M; Cai J; Tang Y; Zhao Q
    Med Hypotheses; 2013 Jul; 81(1):108-10. PubMed ID: 23639284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [MiR-128, a key regulator of oncogenic properties].
    Huang DQ; Guo P; Lv NH; Luo LY
    Mol Biol (Mosk); 2015; 49(1):46-54. PubMed ID: 25916109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function of microRNA-143 in different signal pathways in cancer: New insights into cancer therapy.
    Karimi L; Mansoori B; Shanebandi D; Mohammadi A; Aghapour M; Baradaran B
    Biomed Pharmacother; 2017 Jul; 91():121-131. PubMed ID: 28448866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.